 |
Health knowledge made personal
|
|
|
Health knowledge made personal
|
|
U-M Opens New Research Studies For Emphysema & Other COPD (Medical News Today)
Fri Nov 20 04:39:00 PST 2009
Why do some smokers develop lung disease and others don't? And just how effective is supplemental oxygen therapy in treating patients with emphysema? The University of Michigan Health System will try to find out, through two new multi-center research studies that seek to improve diagnosis and...
Read full article »
|
|
U-M Opens New Research Studies For Emphysema & Other COPD (Newswise)
Thu Nov 19 06:46:34 PST 2009
The University of Michigan Health System will try to find out why some smokers develop lung disease and others don't, through a multi-center research study that seeks to improve diagnosis and treatment for millions of people affected by emphysema, chronic bronchitis and other lung diseases. This...
Read full article »
|
|
New research studies seek to improve diagnosis and treatment for emphysema and other lung diseases (News-Medical-Net)
Thu Nov 19 22:12:45 PST 2009
The University of Michigan Health System will try to find out, through two new multi-center research studies that seek to improve diagnosis and treatment for millions of people affected by emphysema, chronic bronchitis and other lung diseases. Together, those conditions are known as chronic...
Read full article »
|
|
Scientists explore various imaging techniques to gain new insight into lung disease (News-Medical-Net)
Fri Nov 20 21:28:28 PST 2009
Chronic obstructive pulmonary disease (COPD), a respiratory disease commonly known as chronic bronchitis or emphysema, is the fourth leading cause of death worldwide. 600 million people live with COPD and while researchers have yet to find any real treatment or cure, Grace Parraga of Robarts...
Read full article »
|
|
Gaining a better picture of lung disease (EurekAlert!)
Fri Nov 20 06:35:36 PST 2009
( University of Western Ontario ) Chronic obstructive pulmonary disease (COPD), a respiratory disease commonly known as chronic bronchitis or emphysema, is the fourth leading cause of death worldwide. 600 million people live with COPD and while researchers have yet to find any real treatment or...
Read full article »
|
|
Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD) (redOrbit)
Wed Nov 18 04:07:50 PST 2009
LONDON, November 18 /PRNewswire/ -- - New Report Highlights Global Economic Burden of the Disease - An Estimated Two Billion Work Hours Lost Each Week COPD Uncovered, a new report issued today reveals for the first time that people between the ages of 40 to 65 are emerging as the new face of this...
Read full article »
|
|
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations (Business Wire via Yahoo! Finance)
Thu Nov 19 13:36:00 PST 2009
RIDGEFIELD, Conn. & NEW YORK----The U.S. Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application provide substantial and convincing evidence to support the claim that SPIRIVA® HandiHaler® reduces...
Read full article »
|
|
Photo Op: UAB Experts to Participate in National Web Seminar on COPD (The University of Alabama at Birmingham)
Tue Nov 17 14:40:38 PST 2009
A national Web seminar, attended by UAB pulmonary physicians, to raise awareness of chronic obstructive pulmonary disease (COPD). Nov. 18 is World COPD Day.
Read full article »
|
|
Broncus Reports Early EASE Trial Results For Airway Bypass With Exhale(R) Drug-Eluting Stents (Medical News Today)
Wed Nov 18 10:37:19 PST 2009
Broncus Technologies, Inc., a medical technology company focused on developing and commercializing innovative solutions for lung diseases, is announcing early results of the EASE (Exhale Airway Stents for Emphysema) Trial, the first ever, double-blinded, randomized, sham-controlled device study...
Read full article »
|
